Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
European Journal of Pharmacology
|
September 28, 1999
Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats
N Jelovac, P Sikiric, R Rucman, et al.
European Journal of Pharmacology
|
January 27, 1999
New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin
P Sikirić, S Seiwerth, S Desković, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
October 4, 2018
An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system
T Becejac, V Cesarec, D Drmic, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
December 6, 2013
Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability
R Klicek, D Kolenc, J Suran, et al.
Current Medicinal Chemistry
|
February 4, 2012
Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157
P Sikiric, S Seiwerth, R Rucman, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
April 15, 2010
Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats
S Ilic, I Brcic, M Mester, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
December 30, 2011
BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure
I Petrovic, I Dobric, D Drmic, et al.
Life Sciences
|
April 9, 2001
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice
I Bilic, I Zoricic, T Anic, et al.
Inflammopharmacology
|
December 23, 2006
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response
P Sikiric, S Seiwerth, L Brcic, et al.
Bone Marrow Transplantation
|
June 9, 2016
High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD
E Bilic, V Delimar, L Desnica, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
European Journal of Pharmacology
|
September 28, 1999
Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats
N Jelovac, P Sikiric, R Rucman, et al.
European Journal of Pharmacology
|
January 27, 1999
New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin
P Sikirić, S Seiwerth, S Desković, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
October 4, 2018
An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system
T Becejac, V Cesarec, D Drmic, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
December 6, 2013
Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability
R Klicek, D Kolenc, J Suran, et al.
Current Medicinal Chemistry
|
February 4, 2012
Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157
P Sikiric, S Seiwerth, R Rucman, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
April 15, 2010
Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats
S Ilic, I Brcic, M Mester, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
December 30, 2011
BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure
I Petrovic, I Dobric, D Drmic, et al.
Life Sciences
|
April 9, 2001
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice
I Bilic, I Zoricic, T Anic, et al.
Inflammopharmacology
|
December 23, 2006
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response
P Sikiric, S Seiwerth, L Brcic, et al.
Bone Marrow Transplantation
|
June 9, 2016
High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD
E Bilic, V Delimar, L Desnica, et al.
Page
of 8